These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28651038)

  • 1. Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Korman BD; Marangoni RG; Hinchcliff M; Shah SJ; Carns M; Hoffmann A; Ramsey-Goldman R; Varga J
    Arthritis Rheumatol; 2017 Oct; 69(10):2062-2068. PubMed ID: 28651038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The profile of adipokines associated with fibrosis and impaired microcirculation in systemic sclerosis.
    Niemczyk A; Waśkiel-Burnat A; Zaremba M; Czuwara J; Rudnicka L
    Adv Med Sci; 2023 Sep; 68(2):298-305. PubMed ID: 37696138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
    Mattuzzi S; Barbi S; Carletto A; Ravagnani V; Moore PS; Bambara LM; Scarpa A
    J Rheumatol; 2007 May; 34(5):997-1004. PubMed ID: 17444587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
    Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
    Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.
    Bernstein EJ; Gordon JK; Spiera RF; Huang WT; Horn EM; Mandl LA
    Rheumatology (Oxford); 2017 Jan; 56(1):87-94. PubMed ID: 28028158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement.
    Neumann E; Lepper N; Vasile M; Riccieri V; Peters M; Meier F; Hülser ML; Distler O; Gay S; Mahavadi P; Günther A; Roeb E; Frommer KW; Diller M; Müller-Ladner U
    Cytokine; 2019 May; 117():41-49. PubMed ID: 30784899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.
    Bossini-Castillo L; Campillo-Davó D; López-Isac E; Carmona FD; Simeon CP; Carreira P; Callejas-Rubio JL; Castellví I; Fernández-Nebro A; Rodríguez-Rodríguez L; Rubio-Rivas M; García-Hernández FJ; Madroñero AB; Beretta L; Santaniello A; Lunardi C; Airó P; Hoffmann-Vold AM; Kreuter A; Riemekasten G; Witte T; Hunzelmann N; Vonk MC; Voskuyl AE; de Vries-Bouwstra J; Shiels P; Herrick A; Worthington J; Radstake TRDJ; Martin J;
    J Rheumatol; 2017 Oct; 44(10):1453-1457. PubMed ID: 28668810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adipokines in systemic sclerosis: a missing link?
    Żółkiewicz J; Stochmal A; Rudnicka L
    Arch Dermatol Res; 2019 May; 311(4):251-263. PubMed ID: 30806766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.
    Masui Y; Asano Y; Akamata K; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Rheumatol Int; 2014 Aug; 34(8):1165-70. PubMed ID: 24141536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.
    Assous N; Allanore Y; Batteux F; Meune C; Toulon P; Weill B; Kahan A
    Clin Exp Rheumatol; 2005; 23(2):199-204. PubMed ID: 15895890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis.
    Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
    J Dermatol; 2015 May; 42(5):461-6. PubMed ID: 25766303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.
    Arakawa H; Jinnin M; Muchemwa FC; Makino T; Kajihara I; Makino K; Honda N; Sakai K; Fukushima S; Ihn H
    Exp Dermatol; 2011 Sep; 20(9):764-6. PubMed ID: 21615510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
    Stefanantoni K; Sciarra I; Vasile M; Badagliacca R; Poscia R; Pendolino M; Alessandri C; Vizza CD; Valesini G; Riccieri V
    Reumatismo; 2015 Mar; 66(4):270-6. PubMed ID: 25829187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Risk Score impact on susceptibility to systemic sclerosis.
    Bossini-Castillo L; Villanueva-Martin G; Kerick M; Acosta-Herrera M; López-Isac E; Simeón CP; Ortego-Centeno N; Assassi S; ; ; ; ; Hunzelmann N; Gabrielli A; de Vries-Bouwstra JK; Allanore Y; Fonseca C; Denton CP; Radstake TR; Alarcón-Riquelme ME; Beretta L; Mayes MD; Martin J
    Ann Rheum Dis; 2021 Jan; 80(1):118-127. PubMed ID: 33004331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.
    Kawaguchi Y; Tochimoto A; Hara M; Kawamoto M; Sugiura T; Katsumata Y; Okada J; Kondo H; Okubo M; Kamatani N
    Arthritis Res Ther; 2006; 8(4):R104. PubMed ID: 16813666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.
    Lee YH; Song GG
    Z Rheumatol; 2017 Nov; 76(9):789-797. PubMed ID: 27515182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population.
    Wipff J; Dieudé P; Guedj M; Ruiz B; Riemekasten G; Cracowski JL; Matucci-Cerinic M; Melchers I; Humbert M; Hachulla E; Airo P; Diot E; Hunzelmann N; Caramaschi P; Sibilia J; Valentini G; Tiev K; Girerd B; Mouthon L; Riccieri V; Carpentier PH; Distler J; Amoura Z; Tarner I; Degano B; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2010 Oct; 62(10):3093-100. PubMed ID: 20556823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome.
    Chedraui P; Pérez-López FR; Escobar GS; Palla G; Montt-Guevara M; Cecchi E; Genazzani AR; Simoncini T;
    Maturitas; 2014 Sep; 79(1):86-90. PubMed ID: 25015014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.